TipRanks
Insulet (PODD)
NASDAQ:PODD
US Market
PODD
Insulet
RESEARCH TOOLSreports
Want to see PODD full AI Analyst Report?

Insulet (PODD) Stock Forecast & Price Target

1,109 Followers
See the Price Targets and Ratings of:

PODD Analyst Ratings

Moderate Buy
20Ratings
Moderate Buy
10 Buy
10 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Insulet
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PODD Stock 12 Month Forecast

Average Price Target

$165.00
▲(15.34% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Insulet in the last 3 months. The average price target is $165.00 with a high forecast of $190.00 and a low forecast of $143.00. The average price target represents a 15.34% change from the last price of $143.05.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"129":"$129","314":"$314","175.25":"$175.3","221.5":"$221.5","267.75":"$267.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":190,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$190.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":165,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$165.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$143.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[129,175.25,221.5,267.75,314],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.79,135.34461538461537,139.89923076923077,144.45384615384614,149.00846153846152,153.56307692307692,158.1176923076923,162.6723076923077,167.22692307692307,171.78153846153845,176.33615384615385,180.89076923076922,185.44538461538463,{"y":190,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.79,133.42153846153846,136.05307692307693,138.68461538461537,141.31615384615384,143.9476923076923,146.57923076923078,149.21076923076922,151.84230769230768,154.47384615384615,157.10538461538462,159.73692307692306,162.36846153846153,{"y":165,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130.79,131.72923076923075,132.66846153846154,133.6076923076923,134.54692307692306,135.48615384615385,136.42538461538462,137.36461538461538,138.30384615384614,139.24307692307693,140.1823076923077,141.12153846153845,142.06076923076924,{"y":143,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":305.98,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.01,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.83,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":284.24,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.62,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":245.45,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.04,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":175.04,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.13,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":159.79,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.35,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.38,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.79,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$190.00Average Price Target$165.00Lowest Price Target$143.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on PODD
Matthew Taylor
Jefferies
Jefferies
$275→$190
Buy
32.82%
Upside
Reiterated
10/12/26
Insulet price target lowered to $190 from $275 at JefferiesInsulet price target lowered to $190 from $275 at Jefferies
Leerink Partners Analyst forecast on PODD
Mike Kratky
Leerink Partners
Leerink Partners
$145→$143
Hold
-0.03%
Downside
Assigned
10/12/26
Insulet (PODD) Gets a Hold from Leerink Partners
Barclays Analyst forecast on PODD
Christopher Pasquale
Barclays
Barclays
$150
Hold
4.86%
Upside
Initiated
10/07/26
Barclays Remains a Hold on Insulet (PODD)
RBC Capital Analyst forecast on PODD
Kendall Au
RBC Capital
RBC Capital
$160
Buy
11.85%
Upside
Reiterated
10/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on PODD
Joanne Wuensch
Citi
Citi
―
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Insulet (NASDAQ: PODD) and General Motors (NYSE: GM)
UBS Analyst forecast on PODD
Patrick Wood
UBS
UBS
$150
Hold
4.86%
Upside
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Evercore ISI Analyst forecast on PODD
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$180
Buy
25.83%
Upside
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on PODD
Jeff Johnson
Robert W. Baird
Robert W. Baird
$248→$175
Buy
22.33%
Upside
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Truist Financial Analyst forecast on PODD
Richard Newitter
Truist Financial
Truist Financial
$210→$153
Hold
6.96%
Upside
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on PODD
Mathew Blackman
TD Cowen
TD Cowen
$294→$144
Hold
0.66%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Stifel Nicolaus Analyst forecast on PODD
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$225→$180
Buy
25.83%
Upside
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Canaccord Genuity Analyst forecast on PODD
William Plovanic
Canaccord Genuity
Canaccord Genuity
$249→$179
Buy
25.13%
Upside
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Deutsche Bank Analyst forecast on PODD
Kieran Ryan
Deutsche Bank
Deutsche Bank
$190→$180
Buy
25.83%
Upside
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on PODD
Lee Hambright
Bernstein
Bernstein
$200→$175
Buy
22.33%
Upside
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
StoneX Analyst forecast on PODD
Bruce Jackson
StoneX
StoneX
$250→$185
Buy
29.33%
Upside
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on PODD
Matthew Taylor
Jefferies
Jefferies
$275→$190
Buy
32.82%
Upside
Reiterated
10/12/26
Insulet price target lowered to $190 from $275 at JefferiesInsulet price target lowered to $190 from $275 at Jefferies
Leerink Partners Analyst forecast on PODD
Mike Kratky
Leerink Partners
Leerink Partners
$145→$143
Hold
-0.03%
Downside
Assigned
10/12/26
Insulet (PODD) Gets a Hold from Leerink Partners
Barclays Analyst forecast on PODD
Christopher Pasquale
Barclays
Barclays
$150
Hold
4.86%
Upside
Initiated
10/07/26
Barclays Remains a Hold on Insulet (PODD)
RBC Capital Analyst forecast on PODD
Kendall Au
RBC Capital
RBC Capital
$160
Buy
11.85%
Upside
Reiterated
10/01/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Citi Analyst forecast on PODD
Joanne Wuensch
Citi
Citi
―
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Insulet (NASDAQ: PODD) and General Motors (NYSE: GM)
UBS Analyst forecast on PODD
Patrick Wood
UBS
UBS
$150
Hold
4.86%
Upside
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Evercore ISI Analyst forecast on PODD
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$180
Buy
25.83%
Upside
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on PODD
Jeff Johnson
Robert W. Baird
Robert W. Baird
$248→$175
Buy
22.33%
Upside
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Truist Financial Analyst forecast on PODD
Richard Newitter
Truist Financial
Truist Financial
$210→$153
Hold
6.96%
Upside
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on PODD
Mathew Blackman
TD Cowen
TD Cowen
$294→$144
Hold
0.66%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Stifel Nicolaus Analyst forecast on PODD
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$225→$180
Buy
25.83%
Upside
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Canaccord Genuity Analyst forecast on PODD
William Plovanic
Canaccord Genuity
Canaccord Genuity
$249→$179
Buy
25.13%
Upside
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Deutsche Bank Analyst forecast on PODD
Kieran Ryan
Deutsche Bank
Deutsche Bank
$190→$180
Buy
25.83%
Upside
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on PODD
Lee Hambright
Bernstein
Bernstein
$200→$175
Buy
22.33%
Upside
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
StoneX Analyst forecast on PODD
Bruce Jackson
StoneX
StoneX
$250→$185
Buy
29.33%
Upside
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Insulet

3 Months
Matthew TaylorJefferies
Success Rate
16/19 ratings generated profit
84%
Average Return
+9.54%
Copying Matthew Taylor's trades and holding each position for 3 Months would result in 84.21% of your transactions generating a profit, with an average return of +9.54% per trade.
1 Year
Matthew TaylorJefferies
Success Rate
13/19 ratings generated profit
68%
Average Return
+16.69%
Copying Matthew Taylor's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +16.69% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
19/31 ratings generated profit
61%
Average Return
+38.08%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 61.29% of your transactions generating a profit, with an average return of +38.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PODD Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
20
16
3
1
0
Buy
21
21
19
12
11
Hold
5
5
13
14
14
Sell
2
2
0
0
0
Strong Sell
0
0
0
0
0
total
48
44
35
27
25
In the current month, PODD has received 11 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. PODD average Analyst price target in the past 3 months is 165.00.
Each month's total comprises the sum of three months' worth of ratings.

PODD Financial Forecast

PODD Earnings Forecast

Next quarter’s earnings estimate for PODD is $1.59 with a range of $1.53 to $1.66. The previous quarter’s EPS was $1.66. PODD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PODD has Performed in-line its overall industry.
Next quarter’s earnings estimate for PODD is $1.59 with a range of $1.53 to $1.66. The previous quarter’s EPS was $1.66. PODD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year PODD has Performed in-line its overall industry.

PODD Sales Forecast

Next quarter’s sales forecast for PODD is $832.71M with a range of $826.33M to $838.10M. The previous quarter’s sales results were $801.70M. PODD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PODD has Performed in-line its overall industry.
Next quarter’s sales forecast for PODD is $832.71M with a range of $826.33M to $838.10M. The previous quarter’s sales results were $801.70M. PODD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year PODD has Performed in-line its overall industry.

PODD Stock Forecast FAQ

What is PODD’s average 12-month price target, according to analysts?
Based on analyst ratings, Insulet’s 12-month average price target is 165.00.
    What is PODD’s upside potential, based on the analysts’ average price target?
    Insulet has 15.34% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PODD a Buy, Sell or Hold?
          Insulet has a consensus rating of Moderate Buy which is based on 10 buy ratings, 10 hold ratings and 0 sell ratings.
            What is Insulet’s price target?
            The average price target for Insulet is 165.00. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $190.00 ,the lowest forecast is $143.00. The average price target represents 15.34% Increase from the current price of $143.05.
              What do analysts say about Insulet?
              Insulet’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of PODD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.